跳至主要内容
临床试验/ISRCTN92021748
ISRCTN92021748进行中(未招募)Unknown

Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol

Tulane University0 个研究点目标入组 115 人开始时间: 2024年9月16日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
115
主要终点
Prevalence of post-tuberculosis lung disease amongst persons completing 6 months of treatment for active TB measured using spirometry and symptom screening at baseline (completion of 6 months of TB treatment) and at 6 months after completion of TB treatment.

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •Primary outcome:
  • •Aged =15 years of age
  • •Enrolled in the National TB Control Program (NTCP) at Carmelo Hospital (CHC) with a GeneXpert-positive sputum
  • •Completed six months of TB treatment and considered TB-cured
  • •Ability to understand and comply with study proceduresSemi-structured key-informant interviews:
  • •Participants at the central level of the NTCP in Maputo (Mozambique’s capital city)
  • •Administrators of CHC and at each of the three selected peripheral health facilities
  • •Clinicians (physician, medical technician, and nurse) responsible for implementing the spirometry screening program at CHC, as well as all clinicians responsible for treating TB at each of the three selected peripheral health facilities

排除标准

  • •Less than 15 years of age
  • •Active respiratory symptoms at the time of screening that are indicative of a new acute respiratory illness

结局指标

主要结局

Prevalence of post-tuberculosis lung disease amongst persons completing 6 months of treatment for active TB measured using spirometry and symptom screening at baseline (completion of 6 months of TB treatment) and at 6 months after completion of TB treatment.

次要结局

未报告次要终点

研究者

相似试验

Spirometry screening for post-tuberculosis lung... | 临床试验